Biostar Pharmaceuticals, Inc. Finite-Lived Intangible Asset, Expected Amortization, after Year Five
Biostar Pharmaceuticals, Inc. had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $2.84 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2017-11-20
- 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $2.84M.
- 2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $2.78M.
- 2017-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $2.43M.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $2.31M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2017-09-30 | $2.84M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $2.78M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $2.43M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $2.31M 10-K · filed 2017-04-13 |
| 2016-09-30 | $4.08M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $4.13M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $4.34M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $2.29M 10-K · filed 2016-04-14 |
| 2015-09-30 | $6.64M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $7.05M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $7.06M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $3.65M 10-K · filed 2015-04-15 |
| 2014-09-30 | $6.74M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $7.40M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $9.15M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $7.22M 10-K · filed 2014-03-31 |
| 2013-09-30 | $9.42M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $9.89M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $3.48M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $3.54M 10-K · filed 2013-04-15 |
| 2012-09-30 | $3.57M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $3.29M 10-Q · filed 2012-08-14 |